ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.650
-0.050 (-2.94%)
At close: May 20, 2025, 4:00 PM
1.650
0.00 (0.00%)
After-hours: May 20, 2025, 4:00 PM EDT
ESSA Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ESSA Pharma stock has a target of 2.00, which predicts a 21.21% increase from the current stock price of 1.65.
Price Target: $2.00 (+21.21%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 4, 2024.
Analyst Ratings
The average analyst rating for ESSA Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $15 → $2 | Buy → Hold | Downgrades | $15 → $2 | +21.21% | Nov 4, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 4, 2024 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 | Buy | Maintains | $17 | +930.30% | May 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 | Buy | Reiterates | $17 | +930.30% | Dec 13, 2023 |
Financial Forecast
Revenue This Year
n/a
from 495.69M
Revenue Next Year
n/a
EPS This Year
-0.57
from -0.64
EPS Next Year
-0.17
from -0.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 23.4M | 183.1M | ||
| Avg | n/a | 22.7M | 177.9M | ||
| Low | n/a | 21.8M | 170.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 706.0% | ||
| Avg | - | - | 683.0% | ||
| Low | - | - | 652.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.33 | 0.17 | 3.18 | ||
| Avg | -0.57 | -0.17 | 1.30 | ||
| Low | -0.70 | -0.48 | -0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.